Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with cystic fibrosis
- People who have been taking the combination medication Elexacaftor-Tezacaftor-Ivacaftor (also known as Kaftrio or Trikafta) for at least 6 months
- People who are enrolled in a social security scheme (confirm with trial site)
- People who have read and signed a form giving their informed consent to participate
Who may not be able to join:
- Women who are pregnant or breastfeeding
- People who are under a legal protection order, guardianship, or curatorship (a formal arrangement where another person or authority manages their affairs)
- People whose doctor has not approved physical activity for them, or who have physical or movement limitations that prevent them from taking part in physical activity
- People who are unable to follow the requirements of the DIAPASOM program (confirm with trial site for details on what this involves)
- People who have difficulty understanding and completing self-reported questionnaires
- People who wear a pacemaker or have a metal prosthesis (an artificial body part containing metal)
- People who have fluid retention (a condition where excess fluid builds up in the body)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Julie MANKIKIAN, MD, University Hospital, Tours
Phone: 0247474747
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evolution of percentage of patients lean mass as a percentage of body mass
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.